QA submission final closing date for 2021 is 12 November 2021 5pm, any submissions made after this date will be reviewed after 31 January 2022.
The following definitions apply and should help you to determine the level of risk of your intended activity.
The NHMRC National Statement on Ethical Conduct in Human Research (2007 updated 2018) (Chapter 2.1), defines negligible risk as "when there is no foreseeable risk of harm or discomfort; and any foreseeable risk is no more than inconvenience. Where the risk, even if unlikely, is more than inconvenience, the research is not negligible risk". For example
The NHMRC: Ethical Considerations in Quality Assurance and Evaluation Activities (2014), state that the primary purpose of these studies' "is to monitor or improve the quality of service delivered by an individual or an organisation." Audits form part of standard hospital monitoring processes and are not research. Furthermore, evaluation is a term that generally encompasses the systematic collection and analysis of information to make judgements, usually about the effectiveness, efficiency and/or appropriateness of an activity for example
Irrespective of whether an activity is called research or QA or evaluation, those conducting the activity must consider whether the people involved (e.g. participants, staff or the community) will be exposed to any risk, burden, inconvenience or possible breach of their privacy.
An activity where the primary purpose is to monitor or improve the quality of service delivered by an individual or an organisation is a QA activity. Terms such as 'peer review', 'quality assurance', 'quality improvement', 'quality activities', 'quality studies' and 'audit' are often used interchangeably. We use the term 'quality assurance' to include all of these terms.
Download Checklist hereInvestigators are advised to check that the intended project does NOT include any activities that would increase the risk profile of the project and accordingly escalate it to a higher level of ethical review. The checklist below has been provided to assist researchers to choose the correct submission pathway for their Project.
LEVEL OF RISK CHECKLIST
an activity which is greater than negligible risk e.g. Vulnerable groups are
sensitive questions being asked?
participation involve more than inconvenience?
the activity potentially infringe the privacy or professional reputation of
participants, or organisations?
identifiable data be accessed by staff who do not have rightful clinical
access and/or consent was not obtained to use this data for research?
there a reasonable expectation that the project findings arising from the
project may be clinically relevant to the individual participants e.g. the
disclosure of genetic testing/results?
a project that will last for more than two years?
a multi-site study?
If you answer YES to any of the questions above the intended project is NOT APPLICABLE for submission via the QA/NRR submission pathway.
In each of these cases, a standard research submission for research ethics approval is required. See more information here to determine the review pathway suitable for your project.
If you answered NO to all of the questions above the intended project IS APPLICABLE for submission via the QA/NRR submission pathway.
Back to Top
Western Health have mandatory protocol templates that have been developed specifically to be used for submission of projects via the QA/NRR submission pathway. These templates provide the level of information required by both the Office for Research and the LREP to review these types of applications.
Before you start please determine the category of your intended activity and then select the relevant WH protocol template to be used.
A. CLINICAL AUDIT
Complete the Clinical Audit Protocol template (right hand side download)
The proposed access is directly related to a quality/evaluation activity e.g. training or health service delivery evaluation, where the proposed investigators:
Complete the WH QA NRR protocol template (right hand side download)
The research involves the potential for no more than negligible risk, for example:
If the proposed project meets one of the above categories it will be eligible for submission via the Quality Assurance form pathway on Ethics Review Manager (ERM). Complete the correct protocol template and then submit via the ERM Portal
The following pathway has been developed to expedite the approval of negligible risk type research or provide the oversight for quality and evaluation activity as described above.
1. Quality Assurance, Clinical Audit and Evaluation Activity – The Office for Research will review and provide an organisational oversight approval (i.e. a notification that the activity meets the criteria for exemption of ethics review)
2. Negligible Risk Type Research – to apply for ethics approval from the Western Health Low Risk Ethic Panel (LREP) via an expedited pathway (reviewed out of session).
If you would like advice regarding the process for submission of a QA/NRR Applications, or would like guidance to complete the documents, please contact Mrs. Kerrie Russell (03) 8395 8074 at the Office for Research [email protected].
It is best that you make contact with the Office for Research prior to submission if you are not sure of the process or are new to Research and QA submissions.
Please ensure you are familiar with the WH Research Code of Conduct (2018) and the WH Standard Operating Procedures - Good Clinical Practice (WH SOP-GCP) for research. The WH Office for Research may conduct an audit at any time.
Back to top
All submissions for these types of activities at Western Health are now made via the ERM website portal by completion of the QA VIC Form and including other relevant documentation that is requested.
Email [email protected] with the following information to receive a QA reference number:
You will receive a QA local reference number to be quoted within your documents when you submit.
Please attach the applicable protocol:
A: The WH Clinical Audit Protocol template
B & C: WH Negligible Risk/QA/QI/ protocol template
Useful Assessment Tool (no need to submit for ethics review)
Privacy & Data Management
We are all responsible for the protection and handling of private personal information at Western Health. The WH Office for Research highly recommends that a Privacy Impact Assessment (PIA) is performed and completed during the development and planning of your project and protocol to identify potential privacy risks and to implement mitigation strategies to comply with the Privacy & Data Protection Act 2014 (PDP Act 2014) before a project commences. Please see the Office of the Victorian Information Commission (OVIC) website for the PIA and guidelines. Please note that this form does not need to be submitted to the Office for Research. For guidance and review of data management plans, contact the WH Corporate Records Manager, Alan Kong [email protected]. Please also note that if your project is audited, this document may be requested for review as a supporting document.
This QA VIC Form is to be completed on the Ethics Review Manager (ERM) Portal.
Please ensure to upload all documents onto ERM.
NOTE: all investigators or named department heads will need to create an account or already have an ERM account to electronically sign. You will find instructions in the HELP section of the ERM website that will advise how to ensure that the form is signed by all parties.
ERM Applicant User Guide -DHHS
Curriculum Vitae using the WH CV template from all investigators with signatures indicating that they have read and understood the WH Research Code of Conduct (2018).
A revised CV and declaration is required every 2 years
It is mandatory for the Principal investigators to have completed GCP Training, please provide a copy of their completion certificate.
It is also recommended that all investigators undertaking research complete GCP Training.
GCP Training must be valid and completed within the last 3 years.
Submit the following if applicable to your project activity:
1. Submission to be made through ERM Portal
When you submit your ERM application, please attach ALL documents above to the form online.
Please ensure you name the file correctly. It should be uploaded using the document name, version and date that appear on the opened file. Do NOT use the date of upload as the document date.
Mandatory Electronic file name convention:
To ensure the electronic copies submitted are easily identifiable, the format outlined below must be used for all electronic files. As shown in example below, include version numbers and dates in the file name.
Projects submitted with documents that do not follow the below naming convention/format will not be considered and will be returned via email to sender.
Convention: [QA Reference/ERM Project ID] [Document Name] [version number] [Date DDMMMYY]
E.g. QA2020.123 QA Application Checklist 01Jan19; 41234 Protocol v1 01Jan19; 41234 Data Collection Sheet v1 01Dec18.
CV's GCP & Codes (where applicable) to be named as
PLEASE NOTE: Applications that do not have documents named correctly will be deemed invalid and sent back to the researcher for resubmission.
2. Notify ethics of your formal application via Email: [email protected] with your QA local reference number & ERM ID reference in the subject title. DO NOT attach documents to email, documents should be submitted through ERM.
3. IMPORTANT: Submissions will not be processed unless the notification email has been received by the [email protected] email.
QA submissions can be made at any time independent of the Low Risk Ethics Panel Submission Dates.
What can you expect once you have submitted a Clinical Audit/QA or NRR Application for review at Western Health?
The submission will be deemed invalid and the application will be rejected and a revision and resubmission will be required if the submitted documents DO NOT follow the mandatory naming convention, the ERM application is NOT signed by ALL investigators and Head/Supporting Heads of Departments, or the incorrect WH protocol template has been completed for the proposed activity to be undertaken during the project.
If there are any further requirements you will be advised via email and asked to make the required revisions and update your submission on ERM.
If requested; upon receipt of a satisfactory resubmission or revision; the application will then be reviewed by the Office for Research and if applicable by a member of the Low Risk Ethics Panel. The reviewer may take 2 weeks to review the application.